Michael Barbella, Managing Editor04.13.22
Guard Medical Inc. is touting promising results from its post-market NPseal study.
The company completed the at Keck Medical Center of USC (Los Angeles). NPseal is the next-generation, all-in-one Negative Pressure Wound Therapy (NPWT) system for treating closed surgical incisions. Guard Medical’s simple cost-effective NPWT NPseal is a wearable dressing with an integrated pump that establishes and maintains negative pressure with just a few pinches.
“A total of 30 patients were included in this study. The application of negative pressure wound therapy was simple and the dressing maintained negative pressure for the duration of therapy,” stated Joongho Shin, M.D., colon and rectal surgeon, Keck Medicine of USC, and principal investigator of the study. “At 30-day follow-up, none of the patients had any signs of Surgical Site Infections or other wound complications. The majority of the patients reported the device as “very comfortable.”
NPWT has been shown to reduce surgical site infections (SSI) in a large number of peer reviewed articles but is in limited use due to its high cost and complexity. While being easy-to-use, NPseal delivers the same NPWT as current more expensive and complex NPWT devices.
“This first study demonstrated quick application and easy activation of the NPseal,” Guard Medical CEO Machiel van der Leest said. “This ease of use combined with its cost effectiveness makes prophylactic use of NPWT for closed surgical wounds possible.”
Guard Medical Inc., a privately-held company, is developing solutions that enables prophylactic NPWT wound care of closed surgical incisions. Guard Medical’s simple NPWT technology originated with NewYork-Presbyterian and Weill Cornell Medicine in response to physician’s identification of unmet needs related to SSI. Current investors include Bpifrance and Matignon Investissement et Gestion.
The company completed the at Keck Medical Center of USC (Los Angeles). NPseal is the next-generation, all-in-one Negative Pressure Wound Therapy (NPWT) system for treating closed surgical incisions. Guard Medical’s simple cost-effective NPWT NPseal is a wearable dressing with an integrated pump that establishes and maintains negative pressure with just a few pinches.
“A total of 30 patients were included in this study. The application of negative pressure wound therapy was simple and the dressing maintained negative pressure for the duration of therapy,” stated Joongho Shin, M.D., colon and rectal surgeon, Keck Medicine of USC, and principal investigator of the study. “At 30-day follow-up, none of the patients had any signs of Surgical Site Infections or other wound complications. The majority of the patients reported the device as “very comfortable.”
NPWT has been shown to reduce surgical site infections (SSI) in a large number of peer reviewed articles but is in limited use due to its high cost and complexity. While being easy-to-use, NPseal delivers the same NPWT as current more expensive and complex NPWT devices.
“This first study demonstrated quick application and easy activation of the NPseal,” Guard Medical CEO Machiel van der Leest said. “This ease of use combined with its cost effectiveness makes prophylactic use of NPWT for closed surgical wounds possible.”
Guard Medical Inc., a privately-held company, is developing solutions that enables prophylactic NPWT wound care of closed surgical incisions. Guard Medical’s simple NPWT technology originated with NewYork-Presbyterian and Weill Cornell Medicine in response to physician’s identification of unmet needs related to SSI. Current investors include Bpifrance and Matignon Investissement et Gestion.